This package insert is continually updated. Please read carefully before using a new pack!
Each teaspoonful (5ml) contains: 4 mg Bromhexine Hcl
Broncholyte is a clinically proven, systematically active mucolytic agent. The moderately rapid onset of action is clinically manifested by an increase in sputum production which becomes evident 2-3 days after initiation of therapy. The breakdown of acid mucopolysaccharide fibres make the sputum thinner and less viscid and therefore more easily removed by coughing. Although sputum volume eventually decreases, its viscosity remains low for as long as treatment with Broncholyte is maintained. There is also an increased response to bronchodilator drugs such as Alupent and Berotec.
All forms of tracheobronchitis, emphysema with bronchitis, pneumoconiosis, chronic inflammatory pulmonary conditions, bronchiectasis, bronchitis with broncho spasm, asthma.
Occasional gastro-intestinal side effects may occur but these are most invariably mild.
Studies in animals have given suggestion that Broncholyte has any teratogenic potential in humans. Nevertheless, as with any other drug, it is advisable to avoid use during the first trimester of pregnancy.
Dosage and administration
Adults and children over 10 years: 10ml (2 teaspoonfuls 3 time daily)
Children 5- 10 years: 5ml (1 teaspoonful) 3 times daily)
Children under 5 years: 2.5 ml (1/2 teaspoonful) 3 times daily
Babies: 1.25ml (1/4 teaspoonful) 3 times daily
At the commencement of treatment it may be necessary to increase the total daily dose up to 48mg in adults. The elixir is suitable for diabetics and small children.
Note. Patients being treated with Broncholyte should be warned to expect an increase in the flow of secretions.
Store in a cool, dry place out of the reach of children
Nigerian-German Chemicals Plc.
Km 38 Lagos-Abeokuta Expressway, Otta,
Ogun State, Nigeria.